FDA approval for fully sterile chlorhexidine gluconate antiseptic skin preparation

0

BD ChloraPrep™ skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the U.S” BD (2019).

BD report “BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep™ skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the U.S.

This new BD ChloraPrep™ product uses a proprietary and patented process to sterilize the antiseptic solution inside the sealed ampoules located in the BD applicator. With the new sterilization process in place, the BD ChloraPrep™ solutions portfolio that undergo this proprietary added level of sterility will now be labeled as a “sterile solution” on all packaging.”

You may also be interested in…


Full Press Release

Share.

Comments are closed.